BCM
INCY icon

Bayesian Capital Management’s Incyte INCY Stock Holding History

Bayesian Capital Management’s Portfolio INCY Stock Details INCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-18,219
Closed -$1.2M – 829
2024
Q3 		$1.2M Buy
18,219
+3,464
+23% +$221K 0.14% 209
2024
Q2 		$894K Sell
14,755
-3,500
-19% -$198K 0.1% 254
2024
Q1 		$1.04M Buy
+18,255
New +$1.1M 0.1% 280
2022
Q2 		– Sell
-2,553
Closed -$203K – 919
2022
Q1 		$203K Buy
+2,553
New +$186K 0.03% 648
2020
Q2 		– Sell
-3,239
Closed -$237K – 634
2020
Q1 		$237K Sell
3,239
-7,280
-69% -$550K 0.05% 531
2019
Q4 		$919K Buy
10,519
+5,442
+107% +$465K 0.16% 190
2019
Q3 		$377K Buy
+5,077
New +$410K 0.07% 324
2018
Q1 		– Sell
-4,900
Closed -$464K – 701
2017
Q4 		$464K Buy
4,900
+2,973
+154% +$311K 0.09% 335
2017
Q3 		$225K Buy
+1,927
New +$244K 0.05% 407
2017
Q2 		– Sell
-1,747
Closed -$234K – 515
2017
Q1 		$234K Buy
+1,747
New +$222K 0.11% 310

Other funds holding INCY

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bayesian Capital Management's INCY Position: Q4 2024 in Review

Bayesian Capital Management sold out of Incyte (INCY) in Q4 2024, closing a stake of 18,219 shares — an estimated $1.2M sold.

Bayesian Capital Management first reported a position in INCY in Q1 2017 and held it in 10 quarters. The position peaked at $1.2M in Q3 2024. 651 funds tracked by Wall St. Rank hold INCY as of Q4 2024.

  • Bayesian Capital Management reported no remaining Incyte position as of Q4 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 18,219 Incyte shares in Q4 2024, an estimated $1.2M.
  • Bayesian Capital Management first reported a position in Incyte in Q1 2017 and held it in 10 quarters.
  • Bayesian Capital Management's Incyte position peaked at $1.2M in Q3 2024.
  • 651 funds tracked by Wall St. Rank held Incyte as of Q4 2024.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.